Isparocto 1000 for intravenous injection contains Turoctocog Alpha Pegol, a recombinant Factor VIII therapy for hemophilia A. Developed by Novo Nordisk Pharma, this injectable (YJ code: 6343454D2021) is available as a 1,000 IU bottle with dissolving solution.
Isparocto 1000 for intravenous injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).